Clik here to view.
PFIZER REPORTS FIRST-QUARTER 2016 RESULTS
Tuesday, May 3rd 2016 at 10:45am UTC First-Quarter 2016 Reported Revenues(1) of $13.0 Billion, Reflecting 26% Operational Growth Driven by 28% Operational Growth from the Innovative Products Business...
View ArticleClik here to view.
Ophthotech Reports First Quarter 2016 Financial and Operating Results
Wednesday, May 4th 2016 at 11:30am UTC – Conference Call and Webcast Today, May 4th, at 8:00 a.m. ET – NEW YORK–(BUSINESS WIRE)– Ophthotech Corporation (Nasdaq:OPHT) today announced financial results...
View ArticleClik here to view.
Acorda Therapeutics Named One of the Best Places to Work for in New York
Wednesday, May 4th 2016 at 11:00am UTC Westchester-based biotechnology leader earns sixth consecutive Top 10 ranking ARDSLEY, N.Y.–(BUSINESS WIRE)– Acorda Therapeutics, Inc. (Nasdaq:ACOR) has been...
View ArticleClik here to view.
Seattle Genetics to Present at Upcoming Investor Conferences
Wednesday, May 4th 2016 at 12:00pm UTC BOTHELL, Wash.–(BUSINESS WIRE)– Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that management will present at the following upcoming investor conferences....
View ArticleClik here to view.
New Oliver Wyman Report Details Disruptive Market Shifts in Healthcare
Tuesday, May 3rd 2016 at 2:30pm UTC Next-Generation Business Design Will Reshape Current $3 Trillion Sick-Care Market into New $6 Trillion Health and Wellness Marketplace NEW YORK–(BUSINESS WIRE)–...
View ArticleClik here to view.
Kamada to Host First Quarter Financial Results Conference Call on May 9, 2016...
Wednesday, May 4th 2016 at 12:30pm UTC NESS ZIONA, Israel–(BUSINESS WIRE)– Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces...
View ArticleClik here to view.
The Pershing Square Sohn Cancer Research Alliance Awards Funding to Seven New...
Wednesday, May 4th 2016 at 2:05pm UTC The Pershing Square Sohn Prize winners are making bold advances in research for all cancers including leukemia, lymphoma, lung, pancreatic, and breast cancer NEW...
View ArticleClik here to view.
22nd Century Comments on Frivolous Lawsuit Filed by Crede
Wednesday, May 4th 2016 at 12:38pm UTC CLARENCE, N.Y.–(BUSINESS WIRE)– 22nd Century Group, Inc. (NYSE MKT: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, has learned...
View ArticleClik here to view.
Thermo Fisher Scientific to Host Analyst Meeting
Wednesday, May 4th 2016 at 8:30pm UTC WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will host its 2016 Analyst...
View ArticleClik here to view.
The NBA and GE Healthcare Announce First Round Research Winners to Address...
Thursday, May 5th 2016 at 11:00am UTC More than $1.5 million awarded as part of unique NBA/GE Healthcare Sports Medicine and Orthopedics Collaboration Six research proposals on tendinopathy from North...
View ArticleClik here to view.
Modern Family Star Eric Stonestreet and His Mom, a Two Time Cancer Survivor,...
Thursday, May 5th 2016 at 11:30am UTC Ready. Raise. Rise. creates a social movement to honor cancer patients and caregivers and helps provide charitable donations to advocacy organizations...
View ArticleClik here to view.
CORRECTING and REPLACING The Pershing Square Sohn Cancer Research Alliance...
Wednesday, May 4th 2016 at 4:59pm UTC The Pershing Square Sohn Prize winners are making bold advances in research for all cancers including leukemia, lymphoma, lung, pancreatic, and breast cancer NEW...
View ArticleClik here to view.
RetroSense Therapeutics to Highlight Contributions to Gene Therapy Research...
Thursday, May 5th 2016 at 2:41pm UTC Focus on using an optogenetics approach to restoring sight ANN ARBOR, Mich.–(BUSINESS WIRE)– RetroSense Therapeutics, a privately-held biopharmaceutical company,...
View ArticleClik here to view.
Synergy Pharmaceuticals Inc. Announces $89.8 Million Registered Direct...
Thursday, May 5th 2016 at 12:00pm UTC NEW YORK–(BUSINESS WIRE)– Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), a biopharmaceutical company focused on the development and commercialization of novel...
View ArticleClik here to view.
22nd Century to Call for National Tobacco Harm Reduction Policy at Tobacco...
Friday, May 6th 2016 at 2:30pm UTC CLARENCE, N.Y.–(BUSINESS WIRE)– 22nd Century Group, Inc. (NYSE MKT: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, announced today...
View ArticleClik here to view.
Celgene CEO Mark Alles Headlines NewYorkBIO Annual Conference, May 11-12
Thursday, May 5th 2016 at 8:18pm UTC NEW YORK–(BUSINESS WIRE)– NewYorkBIO, New York’s life science trade association, today announced that Mark Alles, CEO of Celgene, will headline the NewYorkBIO...
View ArticleClik here to view.
22nd Century Group va réclamer l’adoption d’une politique nationale de...
Friday, May 6th 2016 at 9:28pm UTC CLARENCE, N.Y.–(BUSINESS WIRE)– 22nd Century Group Inc. (NYSE MKT : XXII ), une entreprise de biotechnologies végétales, chef de file de la réduction des méfaits du...
View ArticleClik here to view.
Eagle Pharmaceuticals, Inc. Reports First Quarter 2016 Results; Bendeka...
Monday, May 9th 2016 at 11:00am UTC — Bendeka leads with approximately 77% market share among hospital outpatients and clinics — WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)– Eagle Pharmaceuticals, Inc....
View ArticleClik here to view.
Synergy Pharmaceuticals Inc. Announces Closing of $89.8 Million Registered...
Monday, May 9th 2016 at 8:30pm UTC NEW YORK–(BUSINESS WIRE)– Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), a biopharmaceutical company focused on the development and commercialization of novel...
View ArticleClik here to view.
PerkinElmer to Present at UBS Global Healthcare Conference
Monday, May 9th 2016 at 8:15pm UTC WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today...
View Article